Ruling Affirmed: Florida Third District Court of Appeal (Contested Foreign Judgment Domestication Proceeding) Fort Lauderdale Partners, Jordan Cohen, and Tampa Partner, Ethan Arthur, recently prevailed in a contested foreign judgment domestication proceeding that was heard by the Florida Third District Court of Appeal
Using a lower "maintenance" or "micro-dose" of GLP-1 agonists is a strategy some clinicians use for long-term weight management
[4] Coverage requires BMI 40 AND participation in weight loss program (diet, exercise, behavior therapy) Coverage for Type 2 diabetes remains unchanged Anthem Blue Cross California policies may differ BCBS Massachusetts Starting January 1, 2026, BCBS MA standard plans will exclude GLP-1s including Zepbound, Wegovy, and Saxenda for weight management
Start your weight loss journey today and embrace a life full of vitality, confidence, and improved health
Tracking your progress and adjusting your approach Managing GLP-1 constipation is not a one-size-fits-all proposition